Potential for therapy with AML-derived dendritic cells
Leukemia
.
2001 Apr;15(4):668-9.
doi: 10.1038/sj.leu.2402056.
Authors
D Claxton
1
,
A Choudhury
Affiliation
1
The University of Texas MD Anderson Cancer Center, Houston, USA.
PMID:
11368375
DOI:
10.1038/sj.leu.2402056
No abstract available
Publication types
Review
MeSH terms
Dendritic Cells / immunology*
Humans
Immunotherapy, Adoptive*
Leukemia, Myeloid, Acute / therapy*